WuXi Biologics (Cayman) Inc. (HKG:2269)
32.62
-0.32 (-0.97%)
At close: Dec 5, 2025
WuXi Biologics Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 134,321 | 72,100 | 124,993 | 252,882 | 390,943 | 419,914 | Upgrade
|
| Market Cap Growth | 115.58% | -42.32% | -50.57% | -35.32% | -6.90% | 228.81% | Upgrade
|
| Enterprise Value | 130,683 | 71,052 | 122,776 | 247,673 | 380,146 | 418,224 | Upgrade
|
| Last Close Price | 32.62 | 17.56 | 29.60 | 59.85 | 92.55 | 102.80 | Upgrade
|
| PE Ratio | 30.12 | 20.19 | 33.37 | 50.61 | 93.99 | 209.36 | Upgrade
|
| Forward PE | 23.62 | 17.09 | 22.71 | 37.41 | 77.91 | 168.15 | Upgrade
|
| PS Ratio | 6.11 | 3.63 | 6.66 | 14.65 | 30.95 | 63.00 | Upgrade
|
| PB Ratio | 2.50 | 1.49 | 2.58 | 6.18 | 9.74 | 16.92 | Upgrade
|
| P/TBV Ratio | 2.85 | 1.70 | 2.96 | 6.79 | 10.56 | 17.69 | Upgrade
|
| P/FCF Ratio | 69.68 | 52.62 | 182.37 | - | - | - | Upgrade
|
| P/OCF Ratio | 21.42 | 12.99 | 24.31 | 40.37 | 92.82 | 187.95 | Upgrade
|
| PEG Ratio | 1.24 | 1.99 | 1.39 | 1.02 | 1.99 | 3.92 | Upgrade
|
| EV/Sales Ratio | 5.95 | 3.58 | 6.54 | 14.35 | 30.10 | 62.75 | Upgrade
|
| EV/EBITDA Ratio | 17.14 | 11.42 | 22.61 | 43.22 | 85.50 | 198.82 | Upgrade
|
| EV/EBIT Ratio | 21.72 | 14.56 | 28.34 | 50.36 | 97.69 | 234.41 | Upgrade
|
| EV/FCF Ratio | 67.79 | 51.85 | 179.13 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.11 | 0.10 | 0.12 | 0.13 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 0.73 | 0.82 | 0.89 | 0.86 | 1.18 | 1.85 | Upgrade
|
| Debt / FCF Ratio | 2.90 | 3.84 | 7.33 | - | - | - | Upgrade
|
| Asset Turnover | 0.34 | 0.33 | 0.32 | 0.33 | 0.28 | 0.24 | Upgrade
|
| Inventory Turnover | 6.36 | 6.71 | 5.04 | 4.31 | 3.94 | 4.15 | Upgrade
|
| Quick Ratio | 2.40 | 1.98 | 2.35 | 1.56 | 1.85 | 2.49 | Upgrade
|
| Current Ratio | 2.88 | 2.73 | 2.78 | 1.98 | 2.37 | 3.16 | Upgrade
|
| Return on Equity (ROE) | 10.51% | 8.82% | 8.90% | 13.20% | 13.09% | 10.02% | Upgrade
|
| Return on Assets (ROA) | 5.89% | 5.05% | 4.63% | 5.81% | 5.43% | 4.03% | Upgrade
|
| Return on Capital (ROIC) | 6.64% | 5.79% | 5.51% | 7.00% | 6.47% | 4.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.60% | 9.50% | 8.00% | 10.80% | 8.90% | 6.10% | Upgrade
|
| Earnings Yield | 3.42% | 4.95% | 3.00% | 1.98% | 1.06% | 0.48% | Upgrade
|
| FCF Yield | 1.44% | 1.90% | 0.55% | -0.15% | -0.97% | -1.17% | Upgrade
|
| Buyback Yield / Dilution | 2.55% | 2.80% | 0.62% | 1.04% | -5.05% | -5.30% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.